Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC)

Multiple Cancer Types

The main purpose of this study is to evaluate safety and efficacy in participants treated with concomitant chemoradiation therapy (cCRT) plus M7824 followed by M7824 compared to cCRT plus placebo followed by durvalumab.
Lung, Non Small Cell
II
Horn, Leora
NCT03840902
VICCTHO1917

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: